Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRDF
ICCC
Add up to 3 more stocks
CRDF
Cardiff Oncology, Inc.
-6.14%
$1.07-0.07Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$82.47M
52W Range
$0.76 - $3.31
ICCC
ImmuCell Corporation
+2.26%
$9.97+0.22Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$90.20M
52W Range
$4.52 - $12.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 117.85 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.11 | 2.87 |
| P/S Ratio | 162.34 | 2.94 |
| P/FCF Ratio | N/A | 21.40 |
| EV/EBITDA | N/A | 15.00 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 40.3% |
| Operating Margin | -8256.3% | 12.6% |
| Net Margin | -7884.1% | 2.6% |
| ROE | -150.9% | 2.5% |
| ROA | -107.3% | 1.7% |
| ROIC | -159.3% | 8.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.30 | 4.75 |
| Quick Ratio | 3.30 | 2.71 |
| Debt/Equity | 0.02 | 0.40 |
| Interest Coverage | N/A | 3.76 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.